Arvaya Healthcare board meets on May 28 for FY26 results
Arvaya Healthcare Limited will hold a board meeting on May 28, 2026, to approve the audited financial statements for the quarter and year ended March 31, 2026. The trading window for insiders remains closed until May 30, 2026.

*this image is generated using AI for illustrative purposes only.
Arvaya Healthcare Limited has announced that its board of directors will meet on Thursday, May 28, 2026. The meeting has been convened pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Agenda for the Meeting
The primary agenda for the upcoming board meeting is to consider and approve the audited financial results of the company. The directors will review both the standalone and consolidated financial statements for the fourth quarter and the financial year ended March 31, 2026. The approval will also include the auditors' report on these financial statements.
Trading Window Closure
In compliance with regulatory norms, the company has closed the trading window for dealing in its shares. This restriction applies to directors, promoters, designated persons, and their immediate relatives. The window closed on April 1, 2026, and will remain shut until May 30, 2026. The stock exchanges were previously intimated about this closure on March 26, 2026.
Key Details
| Detail | Information |
|---|---|
| Company Name | Arvaya Healthcare Limited |
| Scrip Code | 524723 |
| Board Meeting Date | May 28, 2026 |
| Financial Period | Q4 and FY Ended March 31, 2026 |
| Trading Window Closure | April 1, 2026 to May 30, 2026 |
How might Arvaya Healthcare Limited's FY2026 annual revenue and profitability figures compare to its previous fiscal year, and what growth trajectory does this signal for the company?
Will the board consider announcing a dividend or any capital allocation strategy alongside the approval of the FY2026 audited financial results?
How could the release of Arvaya Healthcare's Q4 and FY2026 results influence investor sentiment and the stock's performance once the trading window reopens on May 31, 2026?
























